• PDB9 ESTUDIO DE COSTOS DE LA HIPOGLICEMIA EN PACIENTES CON DIABETES MELLITUS TIPO 2 DESDE LA PERSPECTIVA DE SALUD PUBLICA DE CHILE

    Oct 1, 2019, 00:00

  • PSU3 DETERMINACION DE CAMBIOS QUERATOMETRICOS POST QUIRURGICOS EN PACIENTES SOMETIDOS A PRK O LASIK MEDIANTE LASER EXCIMER VISX STAR S4IR

    Oct 1, 2019, 00:00

  • PRO10 EXPERIENCIA INTERNACIONAL EN EL USO DE ANÁLISIS DE DECISIÓN MULTICRITERIO (MCDA) PARA EVALUAR MEDICAMENTOS HUÉRFANOS: SCOPING REVIEW

    Oct 1, 2019, 00:00

  • PMU2 COSTOS DIRECTOS MÉDICOS EN COLOMBIA DESCRITOS EN EL ESTUDIO COMPASS: EVENTOS CARDIACOS AGUDOS MAYORES (MACE) Y EVENTOS ISQUEMICOS SEVEROS EN EXTREMIDADES (MALE)

    Oct 1, 2019, 00:00

  • PCN38 SYSTEMATIC REVIEW OF RISK SHARING AGREEMENT IN ONCOLOGY: ADVANCES OR MORE OF THE SAME?

    Oct 1, 2019, 00:00

  • PCN47 PEG-ASPARAGINASE E L-ASPARAGINASE NATIVA DE ESCHERICHIA COLI NO TRATAMENTO FARMACOLOGICO DA LEUCEMIA LINFOBLASTICA AGUDA EM CRIANCAS E ADOLESCENTES: UMA REVISAO SISTEMATICA

    Oct 1, 2019, 00:00

  • PCV8 COST-EFFECTIVENESS ANALYSIS OF A RHEOLYTIC THROMBECTOMY SYSTEM FOR THE TREATMENT OF DEEP VEIN THROMBOSIS IN MEXICO

    Oct 1, 2019, 00:00

  • CE4 TRATAMIENTOS PARA LOS PACIENTES CON ESCLEROSIS MULTIPLE REMITENTE RECURRENTE CON ALTA ACTIVIDAD DE LA ENFERMEDAD: ANALISIS COSTO EFECTIVIDAD EN MEXICO

    Oct 1, 2019, 00:00

  • PCN48 HEALTH TECHNOLOGY ASSESSMENT DECISIONS IN ONCOLOGY-RELATED TECHNOLOGIES IN BRAZIL: AN ASSESSMENT CONITEC'S RECOMMENDATIONS FROM 2012-2018

    Oct 1, 2019, 00:00

  • PSY2 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA PERUANA

    Oct 1, 2019, 00:00

  • PDG12 EXPERIENCIA INTERNACIONAL EN VALOR TERAPÉUTICO Y PRECIO BASADO EN VALOR. REVISIÓN RÁPIDA DE LA LITERATURA

    Oct 1, 2019, 00:00

  • PCN59 SUBJECT TRAINING IS NEEDED FOR KEY TERMINOLOGY IN ONCOLOGY CLINICAL TRIALS

    Oct 1, 2019, 00:00

  • PNS47 ANÁLISIS PARA LA IMPLEMENTACIÓN DE NUEVOS MODELOS DE ACCESO PARA EL SISTEMA NACIONAL DE SALUD DEL ECUADOR

    Oct 1, 2019, 00:00

  • PNS18 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH PSYCHOSOCIAL FACTORS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PNS48 USE OF REAL WORLD DATA FOR DEVELOPMENT OF AN ALGORITHM TO EVALUATE THE COMPLEXITY OF PEOPLE WITH CHRONIC DISEASES CONTROLLING FOR SOCIOECONOMIC AND ENVIRONMENTAL INEQUALITIES

    Oct 1, 2019, 00:00

  • PMS20 DADOS DE MUNDO REAL DO USO DE IMUNOBIOLOGICOS DE PACIENTES COM ARTRITE REUMATOIDE

    Oct 1, 2019, 00:00

  • PCN64 ANALISIS COMPARATIVO DE LOS COSTOS DEL PACIENTE CON CARCINOMA HEPATOCELULAR ENTRE REGIMENES CONTRIBUTIVO Y SUBSIDIADO

    Oct 1, 2019, 00:00

  • PCN35 BURDEN OF DISEASE FOR ADVANCED BREAST CANCER IN BRAZIL

    Oct 1, 2019, 00:00

  • PND16 PREFERENCES OF PATIENTS FOR FEATURES OF INJECTABLE, ORAL, AND INFUSED DISEASE-MODIFYING TREATMENTS FOR RELAPSE-REMITTING MULTIPLE SCLEROSIS

    Oct 1, 2019, 00:00

  • PMD9 COST-EFFECTIVENESS ANALYSIS OF THREE-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY VERSUS TWO-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAM FOR THE EVALUATION OF PATIENTS WITH MITRAL REGURGITATION WITH INDICATION OF SURGICAL TREATMENT

    Oct 1, 2019, 00:00

  • PCN8 FINANCIAMIENTO DE MEDICAMENTOS ONCOLOGICOS MEDIANTE EL FONDO INTANGIBLE SOLIDARIO DE SALUD DEL PERU

    Oct 1, 2019, 00:00

  • PIN16 ESTIMATED ANNUAL IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINE (PCV) IMMUNIZATION PROGRAM IN COLOMBIA (2011-2018)

    Oct 1, 2019, 00:00

  • Financial Disclosure Information

    Oct 1, 2019, 00:00

  • PND2 TREATMENTS FOR HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS: COST-EFFECTIVENESS ANALYSIS IN COLOMBIA

    Oct 1, 2019, 00:00

  • PDB8 IMPACTO ECONOMICO DE LA DIABETES MELLITUS TIPO II EN EL PERU EN EL ANHO 2017

    Oct 1, 2019, 00:00

  • PDG7 EVALUACION ECONOMICA DE DEXAMETASONA IMPLANTE PARA EL TRATAMIENTO DE PACIENTES CON EDEMA MACULAR DIABETICO CON FALLA A LA TERAPIA ANTI-VEGF (RANIBIZUMAB O AFLIBERCEPT)

    Oct 1, 2019, 00:00

  • PMU3 COSTOS DIRECTOS DE LA ATENCIÓN EN PACIENTES SUSCEPTIBLES DE CUIDADOS PALIATIVOS, EL CASO DE UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN40 COSTS OF COMPREHENSIVE CARE OF HEPATOCELLULAR CARCINOMA IN A MODEL PUBLIC PROVIDER IN CHILE: IS IT POSSIBLE TO PROMOTE FINANCIAL COVERAGE?

    Oct 1, 2019, 00:00

  • PMS12 BENEFICIOS CLINICOS Y ECONOMICOS EN LA IMPLEMENTACION DE UNIDADES DE COORDINACION DE FRACTURAS (FLS) EN MEXICO

    Oct 1, 2019, 00:00

  • PIH3 BUDGET IMPACT ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PDG15 SOLICITAÇÃO DE MEDICAMENTOS DO COMPONENTE ESPECIALIZADO NO ESTADO DE MINAS GERAIS: ESTRATÉGIA PARA REDUÇÃO DO TEMPO DE TRAMITAÇÃO E OTIMIZAÇÃO DESSE PROCESSO

    Oct 1, 2019, 00:00

  • PNS38 INVESTIGATING QUALITY AND PERFORMANCE INDICATORS RELATED TO OUTPATIENT CARE USING THE DELPHI METHOD

    Oct 1, 2019, 00:00

  • PCN27 BUDGET IMPACT ANALYSIS OF MIDOSTAURIN IN PATIENTS WITH NEWLY DIAGNOSED FLT3 MUTATION-POSITIVE ACUTE MYELOID LEUKEMIA

    Oct 1, 2019, 00:00

  • PIH16 PATRONES DE USO DE ANTICONCEPTIVOS HORMONALES EN UNA POBLACIÓN DE COLOMBIA.

    Oct 1, 2019, 00:00

  • PSY10 COST-EFFECTIVENESS ANALYSIS OF DRUG CHALLENGE TEST COMPARED TO SPECIFIC IGE DOSAGE FOR THE DIAGNOSIS OF PATIENTS WITH SUSPECT OF PENICILLIN ALLERGY

    Oct 1, 2019, 00:00

  • PIN7 ECONOMIC EVALUATION OF ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (GENVOYA®) AS A COMPLETE TREATMENT REGIMEN FOR HIV-1 INFECTION IN ADULTS WHO ARE ANTIRETROVIRAL THERAPY-NAÏVE IN MEXICO

    Oct 1, 2019, 00:00

  • PBI8 O IMPACTO ECONOMICO DO PROCESSO DE VERTICALIZACAO NO USO DE IMUNOBIOLOGICOS INDICADOS PARA DOENCA DE CHRON EM UMA OPERADORA DE PLANOS DE SAUDE

    Oct 1, 2019, 00:00

  • PMS6 STANDARD COSTING OF DIRECT COSTS FOR PATIENTS WITH OSTEOARTHROSIS IN THE FIRST YEAR AFTER THE DISEASE WAS DIAGNOSED

    Oct 1, 2019, 00:00

  • PCN55 CALIDAD DE VIDA RELACIONADA CON LA SALUD Y DESENLACES PERCIBIDOS POR PACIENTES CON CANCER DE MAMA EN COLOMBIA

    Oct 1, 2019, 00:00

  • PNS56 ESTIMACIÓN DEL COSTO DOMICILIARIO EN LAS ALTAS TEMPRANAS PARA PACIENTES NO CRÓNICOS EN UNA RED INTEGRAL DE SALUD

    Oct 1, 2019, 00:00

  • CR4 ESTIMATION OF THE ECONOMIC AND HEALTH EFFECTS OF CHRONIC KIDNEY DISEASE IN CHILEAN POPULATION OLDER THAN 60 YEARS OLD

    Oct 1, 2019, 00:00

  • PAM3 COST MINIMIZATION BETWEEN READY TO USE OLIVE OIL-BASED PARENTERAL NUTRITION AND SUBROGATE COMPOUNDED PARENTERAL NUTRITION, ANALYSIS FROM A HIGH SPECIALITY REGIONAL MEXICAN HOSPITAL.

    Oct 1, 2019, 00:00

  • PIN12 COST-EFFECTIVENESS OF INTERFERON-GAMMA RELEASE ASSAY COMPARED TO TUBERCULIN SKIN TEST FOR DETECTION OF LATENT TUBERCULOSIS IN RHEUMATOID ARTHRITIS PATIENTS USING IMMUNOBIOLOGICAL TREATMENTS

    Oct 1, 2019, 00:00

  • PCN58 CANCER PATIENTS PREFER REPORTING SYMPTOMS IN DAILY ELECTRONIC DIARIES AT HOME

    Oct 1, 2019, 00:00

  • HT4 EXPERIENCIAS INTERNACIONALES ACERCA DE LOS CRITERIOS DE DECISIÓN USADOS EN LA PRIORIZACIÓN DE LAS TECNOLOGÍAS DE SALUD

    Oct 1, 2019, 00:00

  • PMH9 IMPACTO DE FACTORES SOCIOLOGICOS EN LA CALIDAD DE VIDA DE ADULTOS MAYORES INSTITUCIONALIZADOS CON DEPRESION: REVISION SISTEMATICA

    Oct 1, 2019, 00:00

  • PMS9 EVALUACIÓN DE LA INCLUSIÓN DE DENOSUMAB EN EL PLAN DE BENEFICIOS DE SALUD EN COLOMBIA PARA EL TRATAMIENTO DE LA OSTEOPOROSIS: ANÁLISIS DE IMPACTO PRESUPUESTAL

    Oct 1, 2019, 00:00

  • PSU8 IS HIP ARTHROSCOPY COST EFFECTIVE IN TREATING FEMOROACETABULAR IMPINGEMENT? A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS

    Oct 1, 2019, 00:00

  • CM3 REVIS SISTEMÃTICAS DOS MODELOS DE ORGANIZAÇÃO DE SISTEMAS PÚBLICOS DE SAÚDE PARA O CUIDADO DA OBESIDADE INFANTIL E SUA EFETIVIDADE NO MUNDO

    Oct 1, 2019, 00:00

  • PRS1 BUDGET IMPACT ANALYSIS OF UMECLIDINIUM VERSUS TIOTROPIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PCN46 ASSESSING THE QUALITY OF THE EVIDENCE OF NIVOLUMAB ACCORDING TO THE HTA REQUIREMENT IN ARGENTINA

    Oct 1, 2019, 00:00

  • MT1 ANÁLISIS COSTO-EFECTIVIDAD DE UN SISTEMA DE TROMBECTOMÍA REOLÍTICA PARA EL TRATAMIENTO DE LA ISQUEMIA AGUDA DE MIEMBROS INFERIORES EN ADULTOS MEXICANOS

    Oct 1, 2019, 00:00

  • PBI9 MEDICATION USE AND REASONS FOR SWITCHING BIOLOGIC THERAPY IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: FINDINGS FROM A GLOBAL SURVEY

    Oct 1, 2019, 00:00

  • PMH11 BURDEN OF MENTAL ILLNESS IN THE PRESENCE OF CHRONIC DISEASES IN THE BRAZILIAN PRIVATE HEALTH

    Oct 1, 2019, 00:00

  • HT3 BASE DE COSTOS UNITARIOS EN SALUD EN ARGENTINA: UNA FUENTE DE INFORMACIÓN CONTINUAMENTE ACTUALIZADA PARA EVALUACIONES ECONOMICAS Y ANALISIS DE IMPACTO PRESUPUESTARIO EN UN SISTEMA DE SALUD FRAGMENTADO

    Oct 1, 2019, 00:00

  • PCN32 PROSTATE CANCER MORTALITY TREND IN BRAZIL: A LINEAR REGRESSION ANALYSIS BETWEEN 1981 AND 2016

    Oct 1, 2019, 00:00

  • PSY3 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA COLOMBIANA

    Oct 1, 2019, 00:00

  • PIH1 COSTOS DIRECTOS FARMACÉUTICOS EN PACIENTES ANCIANOS CON POLIFARMACIA EXTREMA MAYOR DE 20 MEDICAMENTOS EN COLOMBIA

    Oct 1, 2019, 00:00

  • PDB16 AVALIAÇÃO DA EFICÁCIA E SEGURANÇA DO USO DO METIMAZOL EM COMPARAÇÁO A PROPILTIOURACILA PARA HIPERTIREOIDISMO

    Oct 1, 2019, 00:00

  • CR1 LOS COSTOS INDIRECTOS DE LA MORTALIDAD MATERNA EN BRASIL: UN ESTUDIO DE COSTOS DE ENFERMEDADES

    Oct 1, 2019, 00:00

  • CM1 EFECTIVIDAD Y SEGURIDAD DE LA RESECCIÃN MUCOSA ENDOSCÃPICA FRENTE A LA DISECCIÃN SUBMUCOSA EN PACIENTES CON CÃNCER GÃSTRICO TEMPRANO: REVISIÃN SISTEMÃTICA CON METANÃLISIS

    Oct 1, 2019, 00:00

  • PNS16 ANALYSIS OF THE DEMAND AND CONCESSIONS OF THE CONTINUED CASH BENEFIT FOR PERSONS WITH DISABILITIES UNDER 16 YEARS

    Oct 1, 2019, 00:00

  • PDB15 SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITOR IN TYPE 2 DIABETES: PRESCRIPTION PATTERNS AND TREATMENT OUTCOMES IN ARGENTINA

    Oct 1, 2019, 00:00

  • PGI9 PRIOR DIAGNOSIS OF GASTROINTESTINAL DISORDER DOES NOT INCREASE KNOWLEDGE OF GASTROINTESTINAL TERMINOLOGY OR ACCURACY OF SYMPTOM RATING

    Oct 1, 2019, 00:00

  • PCN60 EVALUATION OF EMOTIONAL, SOCIAL AND ACCESS NEEDS OF PATIENTS DIAGNOSED WITH CHRONIC MYELOID LEUKEMIA IN COLOMBIA.

    Oct 1, 2019, 00:00

  • CV2 MODELO PREDICTIVO DEL RIESGO DE MUERTE EN PACIENTES DIABETICOS APLICADO EN UNA COMPAÑIA DE ASEGURAMIENTO EN SALUD DE COLOMBIA

    Oct 1, 2019, 00:00

  • PND17 THE BURDEN OF MIGRAINE IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PCN67 ANALYSIS OF TREATMENT PATTERNS FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE BRAZILIAN SUPPLEMENTARY HEALTHCARE SYSTEM IN DIFFERENT GEOGRAPHIC REGIONS OF BRAZIL

    Oct 1, 2019, 00:00

  • PIN13 BUDGET IMPACT ANALISIS ( BIA) OF THE IMPLEMENTATION OF HIGH-RISK HPV GENOTYPING IN PATIENTS OF THE SOCIAL SECURITY OF ECUADOR (IESS) FOR PREVENTION OF CERVICAL CANCER

    Oct 1, 2019, 00:00

  • CV3 COST-EFFECTIVENESS OF A COMPREHENSIVE INTERVENTION FOR HYPERTENSION CONTROL IN LOW-INCOME SETTINGS IN ARGENTINA: A MARKOV MODEL

    Oct 1, 2019, 00:00

  • PMH3 ESKETAMINE SELF-PAY MODEL FOR TREATMENT RESISTANT DEPRESSION IN MEXICO

    Oct 1, 2019, 00:00

  • PNS41 VALUE BASED HEALTH CARE (CUIDADO BASADO EM VALOR) EN AMERICA LATINA: RESULTADOS PRELIMINARES DE UNA INVESTIGACION CON 40 HOSPITALES DE CINCO PAISES LATINOAMERICANOS

    Oct 1, 2019, 00:00

  • PUK3 COST CONSEQUENCE ANALYSIS OF A REMOTE PATIENT MONITORING PROGRAM TO IMPROVE CLINICAL PRACTICE OF AUTOMATED PERITONEAL DYALISIS IN BRAZIL

    Oct 1, 2019, 00:00

  • PAM1 RESULTADOS DE LA IMPLEMENTACION DEL MODELO DE SOPORTE NUTRICIONAL EN LOS NIVELES HOSPITALARIO Y DOMICILIARIO

    Oct 1, 2019, 00:00

  • PBI6 EVALUATION OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN COLOMBIA: A COST PER RESPONDER ANALYSIS (CPR)

    Oct 1, 2019, 00:00

  • PCN53 EXAMINATION OF PATIENT DELAY AMONG PATIENTS DIAGNOSED WITH PROSTATE CANCER

    Oct 1, 2019, 00:00

  • PBI5 COST OF ADVERSE EVENTS ASSOCIATED WITH TREATMENT WITH BIOLOGICAL DRUGS IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN ARGENTINA

    Oct 1, 2019, 00:00

  • PSY9 PATRONES DE TRATAMIENTO FARMACOLOGICO EN PACIENTES ADULTOS CON DERMATITIS ATOPICA

    Oct 1, 2019, 00:00

  • PDB12 BUDGET IMPACT ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN TYPE 1 DIABETES MELLITUS COMPARED WITH MULTIPLE DAILY INJECTIONS IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • HI3 EVIDENCIA DE LA VIDA REAL EN ARGENTINA: TRATAMIENTO DE PACIENTES CON HEPATITIS C EN EL SISTEMA DE TUTELAJE DE TECNOLOGIAS SANITARIAS EMERGENTES (STTSE)

    Oct 1, 2019, 00:00

  • PMS16 COMPARING QUALITY OF LIFE, SYMPTOMS, AND TREATMENT PATTERNS OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS: FINDINGS FROM A GLOBAL SURVEY

    Oct 1, 2019, 00:00

  • PNS4 TRENDS FOR INTRODUCTION OF APPROVED DRUGS IN NETWORK META-ANALYSIS

    Oct 1, 2019, 00:00

  • PNS9 BUDGET IMPACT OF NEW RECOMMENDATION FOR ATROPINIZATION IN BRAZILIAN GUIDELINES FOR ANTICOLINESTARASIS INTOXICATION

    Oct 1, 2019, 00:00

  • PCN7 COSTOS DE LOS EVENTOS ADVERSOS ASOCIADOS CON EL TRATAMIENTO DEL MIELOMA MULTIPLE REFRACTARIO RECIDIVANTE (MMRR) EN ARGENTINA

    Oct 1, 2019, 00:00

  • PIH9 IMPACTO ECONOMICO DE ANEMIA Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PIH14 BURDEN OF PNEUMOCOCCAL DISEASE HOSPITALIZATIONS IN OLDER ADULTS 60Y+ IN FIVE CAPITALS IN BRAZIL

    Oct 1, 2019, 00:00

  • PNS19 AN ANALYSIS OF CONTINUED CASH BENEFIT: PERSONS WITH DISABILITIES OVER 16 YEARS OLD

    Oct 1, 2019, 00:00

  • PIH23 SISTEMATIZACION DE EXPERIENCIAS EN EL DESARROLLO DE UNA ESTRATEGIA NO CONVENCIONAL PARA EDUCAR EN SALUD A GESTANTES DEL PROGRAMA SER MADRE-HIJO DE MUTUAL SER EPS.

    Oct 1, 2019, 00:00

  • PNS17 SELF-PERCEIVED DISCRIMINATION AMONG INTERNATIONAL MIGRANTS IN CHILE: RESULTS FROM A NATIONAL-BASED SURVEY (CASEN) 2017

    Oct 1, 2019, 00:00

  • PMU12 A NON-COMMUNICABLE DISEASES MULTI-CRITERIA ANALYSIS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PIN25 CALIDAD DE REVISIONES SISTEMATICAS CON EVALUACIONES DE COSTO-EFECTIVIDAD DE LA VACUNA CONTRA ROTAVIRUS DE PAISES LATINOAMERICANOS

    Oct 1, 2019, 00:00

  • PNS34 COMPARING REMUNERATION OF GENERAL PRACTITIONERS IN COUNTRIES WITH BISMARCK- AND BEVERIDGE HEALTH CARE MODELS

    Oct 1, 2019, 00:00

  • PRO5 ASSESSMENT OF COST-EFFECTIVENESS RESULTS FROM ICER ADVANCED THERAPIES MEDICINAL PRODUCTS REVIEWS

    Oct 1, 2019, 00:00

  • PUK6 AN EVALUATION OF THE BRAZILIAN POLICY FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE UNDER THE PERSPECTIVE OF THE PUBLIC HEALTH CARE SYSTEM: WAS IT EFFECTIVE?

    Oct 1, 2019, 00:00

  • CN3 SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF COLORECTAL CANCER SCREENING STRATEGIES FOR THE EARLY DETECTION OF COLORECTAL CANCER IN THE GENERAL POPULATION

    Oct 1, 2019, 00:00

  • PNS6 VALUE-ASSESSMENT FRAMEWORKS: WE CANNOT ESCAPE THE ETHICAL DILEMMAS POSED BY THEIR USE

    Oct 1, 2019, 00:00

  • RE3 RELAPSING-REMITTING MULTIPLE SCLEROSIS: COSTS BENEFITS OF EXPANDING COVERAGE FROM A PUBLIC PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PNS37 REVIEW OF QUALITY AND PERFORMANCE INDICATORS RELATED TO INPATIENT CARE IN SELF-FUNDED HEALTH PLANS

    Oct 1, 2019, 00:00

  • PNS25 COMPARING THE REMUNERATION OF HOSPITAL NURSES IN COUNTRIES WITH BISMARCK AND BEVERIDGE HEALTH CARE SYSTEMS

    Oct 1, 2019, 00:00

  • PND15 CHARACTERIZATION OF THE ARGENTINE POPULATION WITH AT LEAST 4 MONTHLY MIGRAINE DAYS: RESULTS FROM MIGRAINE VOICE SURVEY

    Oct 1, 2019, 00:00

  • PCN9 ANÁLISIS DE IMPACTO PRESUPUESTAL DE LA DETECCIÓN TEMPRANA DEL CÁNCER DE CUELLO UTERINO EN MUJERES DE 30 A 65 AÑOS MEDIANTE TAMIZACIÓN CON TEST DE VPH Y GENOTIPIFICACIÓN FRENTE CITOLOGÍA CONVENCIONAL, EN COLOMBIA

    Oct 1, 2019, 00:00

  • HT1 TRANSFERIBILIDAD DE LAS EVALUACIONES ECONOMICAS PARA LA TOMA DE DECISIONES: UNA REVISION DE REVISIONES SISTEMATICAS

    Oct 1, 2019, 00:00

  • PMU15 A MOBILE PHONE APP HEALTH CARE PROGRAM IN BRAZIL: SELF-REPORTS TO ASSESS DISEASE PREVALENCE

    Oct 1, 2019, 00:00

  • HI2 EVALUATION OF THE MEDICAL PROCEDURES ON AN ADMINISTRATIVE DATABASE TO IDENTIFY PATIENTS WITH SUSPECTED PRE-ECLAMPSIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • TP2 COSTS AND PRESCRIPTION PATTERN OF PATIENTS WITH PSORIATIC ARTHRITIS AND ITS ASSOCIATED COSTS

    Oct 1, 2019, 00:00

  • PMD5 ANALISIS DEL IMPACTO SANITARIO Y PRESUPUESTARIO POR LA INCORPORACION DEL TEST DE HPV CON GENOTIPIFICACION PARA EL TAMIZAJE PRIMARIO DE CANCER CERVICAL EN UNA POBLACION CERRADA DE UN HOSPITAL UNIVERSITARIO DE LA CIUDAD DE BUENOS AIRES

    Oct 1, 2019, 00:00

  • PCN19 ANÃLISE DO CUSTO-EFETIVIDADE DA RADIOTERAPIA COM INTENSIDADE MODULADA NO TRATAMENTO DO CÃNCER DE PRÃSTATA LOCALIZADO

    Oct 1, 2019, 00:00

  • PCN66 IDENTIFICATION OF PATIENTS UNDERGOING TREATMENT OF LUNG CANCER IN THE BRAZILIAN NATIONAL HEALTH SYSTEM (SUS)

    Oct 1, 2019, 00:00

  • PNS57 REAL WORLD EVIDENCE LANDSCAPE IN LATIN AMERICA HEALTH CARE DECISION MAKING: EXPLORING UNDERSTANDING, ACCEPTABILITY AND USE

    Oct 1, 2019, 00:00

  • PND18 THE RESTORE REGISTRY: A RESOURCE FOR MEASURING AND IMPROVING SPINAL MUSCULAR ATROPHY OUTCOMES

    Oct 1, 2019, 00:00

  • PCN26 IMPACTO DE LAS RECAÍDAS EN LOS PACIENTES COLOMBIANOS CON LINFOMA FOLICULAR

    Oct 1, 2019, 00:00

  • PCV10 EPIDEMIOLOGICAL STUDY DESIGN TO UNDERSTAND CARDIOVASCULAR RISK FACTORS AND TREATMENT IN GENERAL PRACTICE PATIENTS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PIN1 COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR HIGH RISK PATIENTS IN THE PERSPECTIVE OF BRAZILIAN NIP

    Oct 1, 2019, 00:00

  • PIT4 SILICONE TAPES FOR PATIENTS WITH FRAGILE SKIN: A SYSTEMATIC REVIEW

    Oct 1, 2019, 00:00

  • PIN21 PROFILING PURCHASE VOLUMES AND EXPENDITURES WITH DIRECT-ACTING ANTIRETROVIRALS FOR HEPATITIS C BY THE BRAZILIAN MINISTRY OF HEALTH, 2015-2018

    Oct 1, 2019, 00:00

  • EP3 CARACTERIZACIÓN EPIDEMIOLÓGICA DE PACIENTES CON ARTRITIS REUMATOIDE ATENDIDOS EN SISTEMA GENERAL DE SEGURIDAD SOCIAL EN SALUD DE COLOMBIA.

    Oct 1, 2019, 00:00

  • CR2 IMPACTO ECONOMICO DE CANCER DE MAMA Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PCN57 PATIENTS WITH CANCER VIEW PHYSICAL SYMPTOMS AND IMPACT OF SYMPTOMS AS IMPORTANT INFORMATION TO PROVIDE HEALTHCARE PROVIDERS ON A DAILY BASIS

    Oct 1, 2019, 00:00

  • PCN65 ANÃLISIS COMPARATIVO DE CUSTOS DE PACIENTES DE CÃNCER POR REGIÃO GEOGRÃFICA

    Oct 1, 2019, 00:00

  • PDG5 BUDGET IMPACT ANALYSIS OF CLADRIBINE IN HIGH DISEASE ACTIVITY RELAPSE REMITTING MULTIPLE SCLEROSIS IN ARGENTINA

    Oct 1, 2019, 00:00

  • PNS21 EFECTIVIDAD DE INTERVENCIONES DE EDUCACION SEXUAL EN ADOLESCENTES: REVISION DE REVISIONES

    Oct 1, 2019, 00:00

  • PND8 ANALISIS DE MINIMIZACION DE COSTOS DE TOXINA ONABOTULINICA A 100 U EN PACIENTES CON BLEFAROESPASMO Y TORTICOLIS ESPASMODICA

    Oct 1, 2019, 00:00

  • PMD6 CENTRIFUGAL VERSUS MEMBRANE THERAPEUTIC PLASMA EXCHANGE: A CHILEAN, MULTI-CENTER, COST-COMPARISON STUDY

    Oct 1, 2019, 00:00

  • PCN22 ESTUDIO DE COSTO EFECTIVIDAD DE RIBOCICLIB/LETROZOL PARA EL TRATAMIENTO DEL CANCER DE MAMA METASTASICO CON RECEPTORES DE HORMONA POSITIVO Y HER-2 NEGATIVO DESDE LA PERSPECTIVA DEL SISTEMA DE SALUD PUBLICO CHILENO

    Oct 1, 2019, 00:00

  • RE4 PROPOSED SOLUTIONS TO ACHIEVING HEALTHCARE SUSTAINABILITY IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PMU4 ESTIMATING THE ECONOMIC BURDEN OF DISEASE FROM WATER, SANITATION AND HYGIENE IN COLOMBIA

    Oct 1, 2019, 00:00

  • PAM4 ANALISE DOS CUSTOS DE TERAPIAS NUTRICIONAIS APOS ACOES DE AUDITORIA: UMA ANALISE DE DADOS DO MUNDO REAL

    Oct 1, 2019, 00:00

  • PNS58 RESULTADOS DE UM PROGRAMA DE ATENDIMENTO EM SAÚDE EM ÁREAS REMOTAS DA AMAZÔNIA OCIDENTAL BRASILEIRA

    Oct 1, 2019, 00:00

  • PCV11 BURDEN OF STERNAL WOUND INFECTIONS FOLLOWING CORONARY ARTERY BYPASS GRAFT PROCEDURE IN SELECT COUNTRIES

    Oct 1, 2019, 00:00

  • PUK1 COST CONSEQUENCE ANALYSIS OF A REMOTE MONITORING PROGRAM TO IMPROVE CLINICAL PRACTICE OF AUTOMATED PERITONEAL DYALISIS IN COLOMBIA

    Oct 1, 2019, 00:00

  • PIN5 CUSTO COM ANTIMICROBIANOS NO TRATAMENTO DE INFECCAO MULTIRRESISTENTE AOS CARBAPENEMICOS: VISAO DE UMA OPERADORA DE SAUDE

    Oct 1, 2019, 00:00

  • PCN31 BURDEN OF DISEASE FOR ADVANCED BREAST CANCER IN MEXICO

    Oct 1, 2019, 00:00

  • PCN2 EFECTIVIDAD DE LA MAMOGRAFIA EN MUJERES MENORES DE 40 AÑOS: REVISION SISTEMATICA.

    Oct 1, 2019, 00:00

  • PIN18 BURDEN OF ILLNESS OF HERPES ZOSTER IN COLOMBIA: AN OBSERVATIONAL STUDY

    Oct 1, 2019, 00:00

  • CN1 CALIDAD DE VIDA RELACIONADA A LA SALUD Y COSTOS DEL SISTEMA DE SALUD, POR PÉRDIDA DE PRODUCTIVIDAD Y OTROS DE PACIENTES CON DIAGNOSTICO DE CÁNCER DE MAMA EN AMÉRICA LATINA Y EL CARIBE: REVISIÓN SISTEMÁTICA Y META-ANALISIS

    Oct 1, 2019, 00:00

  • PSY7 VENOUS THROMBOEMBOLISM DISEASE: DIRECT COSTS ASSOCIATED WITH ITS TREATMENT IN ARGENTINA

    Oct 1, 2019, 00:00

  • PMH4 STROKE IN BRAZIL: COST OF ILLNESS ON THE LENGTH OF SATY IN HOSPITAL

    Oct 1, 2019, 00:00

  • PIH18 EVALUATION OF INFORMATION SHARING IN CONNECTION WITH SCHOOL HEALTH ATTENDANCE AND ITS EFFECTS ON THE ATTENDANCE OF HEALTH SERVICE

    Oct 1, 2019, 00:00

  • PDB5 IMPACTO ECONOMICO DE HIPERTENSION ARTERIAL Y OBESIDAD EN PERU

    Oct 1, 2019, 00:00

  • Copyright/Subscription

    Sep 18, 2019, 08:26

  • Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish Children

    Sep 1, 2019, 00:00

  • Valuing Health States in Russia: A First Feasibility Study

    Sep 1, 2019, 00:00

  • Editorial Board

    Sep 1, 2019, 00:00

  • Factors That Predict Overall Patient Satisfaction With Oncology Hospital Care in Bulgaria

    Sep 1, 2019, 00:00

  • The Value of a Statistical Life-Year in Sub-Saharan Africa: Evidence From a Large Population-Based Survey in Tanzania

    Sep 1, 2019, 00:00

  • Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa

    Sep 1, 2019, 00:00

  • Requirements for a Successful Drug Launch in Small Markets: A Pilot Study in Lebanon

    Sep 1, 2019, 00:00

  • Table of Contents

    Sep 1, 2019, 00:00

  • The Impact of Financial Crisis, Austerity Measures, and Bailout Agreement on Cypriots’ Health: The Memorandum Is Dead, Long Live the Memorandum

    Sep 1, 2019, 00:00

  • Evaluations of Morphine and Fentanyl for Mechanically Ventilated Patients With Respiratory Disorders in Intensive Care: A Systematic Review of Methodological Trends and Reporting Quality

    Sep 1, 2019, 00:00

  • Pseudo-Generics in South Africa: A Price Comparison

    Sep 1, 2019, 00:00

  • The Burden of Macular Diseases in Central and Eastern Europe—Implications for Healthcare Systems

    Sep 1, 2019, 00:00

  • Review of Pharmacoeconomic Studies in Russian Cancer Research: An Outside View

    Sep 1, 2019, 00:00

  • What Is the Value of Innovative Pharmaceutical Therapies in Oncology and Hematology? A Willingness-to-Pay Study in Bulgaria

    Sep 1, 2019, 00:00

  • Cost of Healthcare Associated With Deep Vein Thrombosis in Patients Treated With Warfarin in Turkey: 2010-2013 Database Analysis of a Tertiary Care Center

    Sep 1, 2019, 00:00

  • Willingness-to-Accept and Willingness-to-Pay Ratios of Prevention of Mother-to-Child Transmission Services in a Nigerian Hospital: A Cross-Sectional Contingent Valuation Study

    Sep 1, 2019, 00:00

  • Impact of a Collaborative Pharmaceutical Care Service Among Patients With Diabetes in an Ambulatory Care Setting in Qatar: A Multiple Time Series Study

    Sep 1, 2019, 00:00

  • External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage

    Sep 1, 2019, 00:00

  • Structural Changes in the Hungarian Healthcare System Between 2000 and 2017

    Sep 1, 2019, 00:00

  • Impact of Disparities in Reimbursement Rules Between Public and Private Sectors on Accessibility to Care in Moroccan Mandatory Health Insurance: A Cross-Sectional Study

    Sep 1, 2019, 00:00

  • Analysis of Direct Monthly Cost of Outpatient Hospital-Based Care for Children With Cerebral Palsy in Kano, Nigeria

    Sep 1, 2019, 00:00

  • The Cost of Managing Occupational Injuries Among Frontline Construction Workers in Ghana

    Sep 1, 2019, 00:00

  • Safety-Engineered Syringes: An Intervention to Decrease Hepatitis C Burden in Developing Countries—A Cost-Effectiveness Analysis From Egypt

    Sep 1, 2019, 00:00

  • Copyright/Subscription

    Jun 11, 2019, 09:02

  • Assessing Diabetes Distress Among Type 2 Diabetes Mellitus in Malaysia Using the Problem Areas in Diabetes Scale

    May 1, 2019, 00:00

  • Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran

    May 1, 2019, 00:00

  • From Research to Policy Implementation: Trastuzumab in Early-Stage Breast Cancer Treatment in Thailand

    May 1, 2019, 00:00

  • Long-Term Clinical Benefits of Canagliflozin 100 mg Versus Sulfonylurea in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin in India

    May 1, 2019, 00:00

  • Comparison of Equity Preferences for Life Expectancy Gains: A Discrete Choice Experiment Among the Japanese and Korean General Public

    May 1, 2019, 00:00

  • Utility Measures in Pediatric Temporary Health States: Comparison of Prone Positioning Valuation Through 5 Assessment Tools

    May 1, 2019, 00:00

  • Editorial Board

    May 1, 2019, 00:00

  • Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review

    May 1, 2019, 00:00

  • Budget Impact Analysis of Rotavirus Vaccine Adoption in the Childhood Immunization Schedule of Iran

    May 1, 2019, 00:00

  • Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea

    May 1, 2019, 00:00

  • A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy Versus Chemotherapy Alone for Advanced Nonsquamous Non–Small-Cell Lung Cancer in China

    May 1, 2019, 00:00

  • Revisiting Roles of Health Technology Assessment on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?

    May 1, 2019, 00:00

  • Retraction notice

    May 1, 2019, 00:00

  • Economics of Medical Devices in India

    May 1, 2019, 00:00

  • A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs

    May 1, 2019, 00:00

  • Table of Contents

    May 1, 2019, 00:00

  • The Cost of Hypoglycemia Associated With Type 2 Diabetes Mellitus in Taiwan

    May 1, 2019, 00:00

  • The Economic Burden of Chronic Obstructive Pulmonary Disease in the Asia-Pacific Region: A Systematic Review

    May 1, 2019, 00:00

  • Health Technology Assessment and Its Use in Drug Policies: Singapore

    May 1, 2019, 00:00

  • Healthcare Resource Utilization and Direct Medical Costs for Patients With Osteoporotic Fractures in China

    May 1, 2019, 00:00

  • Health-Related Quality of Life of Pediatric Spinal Surgery Complications

    May 1, 2019, 00:00

  • Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis

    May 1, 2019, 00:00

  • Stewardship as a Fundamental Challenge in Strategic Purchasing of Health Services: A Case Study of Iran

    May 1, 2019, 00:00

  • Economic Evaluations of Dengue Vaccination in the Southeast Asia Region: Evidence From a Systematic Review

    May 1, 2019, 00:00

  • Health Technology Assessment and Its Use in Drug Policy in Malaysia

    May 1, 2019, 00:00

  • Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach

    May 1, 2019, 00:00

  • Medication Adherence and Diabetes Self-Care Activities Among Patients With Type 2 Diabetes Mellitus

    May 1, 2019, 00:00

  • Role of Health Technology Assessment in Drug Policies: Korea

    May 1, 2019, 00:00

  • Healthcare Resource Utilization and the Cost of Care for Mucopolysaccharidosis I Patients in Iran

    May 1, 2019, 00:00

  • Copyright/Subscription

    Dec 19, 2018, 18:04

  • Copyright/Subscription

    Dec 13, 2018, 10:12

  • Good Practices and Principles in Health Technology Assessment in Latin America

    Dec 1, 2018, 00:00

  • Internal Consistency of the SF-6D as a Health Status Index in the Brazilian Urban Population

    Dec 1, 2018, 00:00

  • End-Stage Renal Disease Models in the Americas- Optimizing Resources to Achieve Better Health Outcomes

    Dec 1, 2018, 00:00

  • Ingredientes Farmacéuticos Activos Potencialmente Inapropiados en Adultos Mayores- Lista IFAsPIAM- Panel de Consenso Argentino

    Dec 1, 2018, 00:00

  • Cost-Effective Analysis to Incorporate Non-Drug Interventions to Increase Adherence to Antiretroviral Therapy

    Dec 1, 2018, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »